Daily Download

TNR.Safety_0.jpg

Safety of Biologics & Newer Agents

Jack Cush, MD
IL6%20front%20end%20image.jpg

TNR Grand Rounds:IL-6 in Health & Disease

Jack Cush, MD

Handouts to Dr. Len Calabreses TNR Presentation

TNR.AOSDslides.front%20image.jpg (keep)

TNR Grand Rounds - Evaluation of Febrile Rheumatic Patients

Jack Cush, MD
Tuesday Nite Rheumatology - Grand Rounds Slide set (n=24 slides)
HCQ.CQ_.AE_.jpg (keep)

Anti-malarial Side Effects

Jack Cush, MD
Guidance from the package inserts HCQ & CQ
Covid.stages.jpg (keep)

Stages of COVID-19

Jack Cush, MD
ISR2.jpg

Injection Site Reactions

Jack Cush, MD
ISRs are common with biologic use
AOSD.ACR_.MTP_.2019.jpg

Adult Stills Disease & Febrile Disorders

Jack Cush, MD
Slide set on Febrile Disorders and AOSD from ACR19
Biosimilars.Updated.1119.jpg

New Biosimilars for Rheumatology - 2019

Jack Cush, MD
4 Slides Reviewing 11 Biosimilars Approved and Indications
Adverse%20Effects%20new%20agents%20Oct%202019.Cush_.jpg

Adverse Effects of Newer Agents 2019

Jack Cush, MD
Safety of Biologics and JAKS - KRA 2019 Presentation
Screen%20Shot%202019-08-12%20at%201.31.07%20PM.png

CANTOS vs. CIRT Trial Comparison

Tammy J. Tilley
New.Biosimilars.0719.jpg

anti-TNF Biosimilars in USA

Jack Cush, MD
UPDATED - there are now 9 biosimilar versions of TNF inhibitors
Screen%20Shot%202019-06-04%20at%207.52.57%20AM.png

FDA Reviews Febuxostat CV Safety

Tammy J. Tilley

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×